Clinical trial
Pilot Study Combining Arginine Depletion and Checkpoint Inhibition in Uveal Melanomas
NCT03922880 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study Combining Arginine Depletion and Checkpoint Inhibition in Uveal Melanomas
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 16, 2019
- Completion date
- January 20, 2023
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.